Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
|
|
Synonyms | Methenolone; Methylandrostenolone; 1-Methyl-5α-androst-1-en-17β-ol-3-one; 1-Methyl-4,5α-dihydro-δ1-testosterone; 1-Methyl-δ1-DHT |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ECHA InfoCard | 100.005.285 |
Chemical and physical data | |
Formula | C20H30O2 |
Molar mass | 302.46 g·mol−1 |
3D model (Jmol) | |
|
|
|
|
Metenolone (brand names Primobolan, Nibal) or methenolone, also known as methylandrostenolone, as well as 1-methyl-4,5α-dihydro-δ1-testosterone (1-methyl-δ1-DHT) or as 1-methyl-5α-androst-1-en-17β-ol-3-one, is a long-acting anabolic-androgenic steroid (AAS) that is marketed for medical use. It is a naturally occurring steroid, found within the adrenal glands of pregnant domesticated felines. Metenolone itself is not used in medicine; as a pharmaceutical drug, it is supplied as metenolone acetate for oral administration and as metenolone enanthate for depot intramuscular injection. Adult doses for the treatment of aplastic anemia are usually in a range of 1–3 mg/kg per day.
Adverse side effects include fluid and electrolyte retention, hypercalcaemia, increased bone growth and skeletal weight. In men, additional side priapism, azoospermia, hirsutism, male pattern baldness, acne and oedema. In women, side effects include virilization, amenorrhoea, menstrual irregularities, suppressed lactation, and increased libido. In children, side effects may include virilization symptoms. Metenolone may enhance effects of antidiabetics, ciclosporin, levothyroxine, warfarin. Resistance to the effects of neuromuscular blockers may occur, and metenolone also has the potential to interfere with glucose tolerance and thyroid function tests.